Pharmaceutical Executive-12-01-2015

How a broader “value” understanding can benefit brand teams.

Cleveland Clinic’s Top Medical Innovations for 2016.

The eight trends brought on by “once-and-done” interventions that may transform thinking around healthcare marketing.

Pharm Exec talks with David Dosa, a leading physician in geriatric medicine, whose famous work with a cat named oscar in end-of-life diagnostics became the stuff of therapeutic legend.

A Pharm Exec conversation with AmerisourceBergen CEO Steve Collis

Drug pricing backlash threatens regulatory reform, R&D advances

Senior Editor Casey McDonald visits with industry and regulatory officials in Bogotá to discuss colombia’s strategy for growing its life sciences enterprise, and whether it can be a stable force amid the region’s historically challenging macroeconomic and political fluctuations.

A new discipline-population health-contests disease treatment as an end in itself. It asks: besides advancing the science of medicine, what do biopharmaceuticals actually do to improve health overall?

The Council of Europe is the latest group to jump into the drug-pricing debate blazing its way through continent.